Published hearing · house
H.Hrg.118
THE ROLE OF PHARMACY BENEFITS MANAGERS IN PRESCRIPTION DRUG MARKETS PART III: TRANSPARENCY AND ACCOUNTABILITY
CHRG-118hhrg56324
Publication
2024-07-23 · GovInfo record 2024-10-31 · OTHERPART
No committee proceeding is explicitly associated with this publication.
Witness lines from the publication
- David Joyner, President, CVS Caremark, Executive Vice President, CVS Health
- Adam Kautzner, PharmD, President, Express Scripts and Evernorth Care Management
- Patrick Conway, MD, MSc, CEO, Optum Rx